Navigation Links
Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
Date:5/14/2009

kaging components that take into account many of the dexterity challenges RA patients may face. The prefilled syringe resulting from the partnership with OXO(R) was designed for use by patients with different grip styles and strengths.

"This syringe, a result of our partnership with OXO(R), demonstrates UCB's commitment to patients with severe diseases. I am proud of the fact that people living with rheumatoid arthritis worked directly with the design and engineering teams to develop this syringe. We have designed a syringe that that takes into account some of the challenges that come with self-injection. UCB has gone beyond providing a new effective treatment option. Our long-term partnership with OXO(R) will allow us to help make everyday living easier for rheumatoid arthritis patients." said Roch Doliveux, Chief Executive Officer of UCB. "In addition, we are pleased to offer people with Crohn's disease in the U.S. the option of self-administering Cimzia(R) using this newly designed syringe. Cimzia(R) patients will now have the convenience of at-home self-injections," said Doliveux.

"OXO(R) was built on the foundation of Universal Design, which focuses on creating easy and comfortable-to-use products for the widest spectrum of users possible," said Alex Lee, President of OXO(R). "In partnering with UCB, we were able to apply our design principles in a new setting. The result is a prefilled syringe that helps provide comfort and control for a wide variety of patient self-administration abilities and user styles."

The Design Process

The development of UCB's new prefilled syringe was initiated when UCB patient research identified that self-injection was a challenge for many people with RA.

UCB and OXO(R) brought in patients to assess the syringes available in the market place and the UCB prototype. This led to the redesign of many aspects of the syringe and its packaging. Specificall
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 1Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 2Tepnel Pharmaceutical Services to Offer DNA Genotek 26apos 3Bs Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 15012 3Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 1Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 2Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE Siemens and Toshiba Scanners 62332 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 1Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 6615 4
Other Medicine News:Health News:The Children's Hospital Gets Special Gift from 'Tour de Kids' Charity Bike Ride 2Health News:The Children's Hospital Gets Special Gift from 'Tour de Kids' Charity Bike Ride 3Health News:J.D. Power and Associates Reports: Rush-Copley Medical Center Recognized for Third Consecutive Year for Providing an Outstanding Inpatient Experience 2Health News:J.D. Power and Associates Reports: Rush-Copley Medical Center Recognized for Third Consecutive Year for Providing an Outstanding Inpatient Experience 3Health News:Andrew Lessman's TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System 2Health News:Andrew Lessman's TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System 3Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 2Health News:Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill 3Health News:Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment 2Health News:Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment 3Health News:Help Raise Awareness of Obesity - Annual 'Walk From Obesity' Invites Participants to Join a Walk in Their Local Area 2